Rosuvastatin treatment is associated with a decrease of serum oxidised low-density lipoprotein/beta2-glycoprotein i complex concentration in type 2 diabetes

Paul Rj Ames, Alfredo Ortiz-Cadenas, Ignacio Garcia-De La Torre, Arnulfo Nava, Aldo Oregon-Miranda, Joana R. Batuca, Kazuo Kojima, Luis R. Lopez, Eiji Matsuura

Research output: Contribution to journalArticle

11 Citations (Scopus)

Fingerprint Dive into the research topics of 'Rosuvastatin treatment is associated with a decrease of serum oxidised low-density lipoprotein/beta2-glycoprotein i complex concentration in type 2 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences